|   | 
                  
                       | 
                      | 
                    
                        
                            
                                | 
                                  
                                 | 
                             
                             |  
                            
                                
                                    
                                        
  
    
	  | 
   
  
    
        
          |   | 
          
              
                | 
                    ÇÏÀ̷μÕÅ©¸²(È÷µå·ÎÄÚ¸£Æ¼¼Õ) 20g  HYROSONE CREAM[Hydrocortisone]  
                    
                 | 
               
              
                | 
                     ÀϹÝÀǾàǰ | ±Þ¿©  
                        
                    	
                    
                 | 
               
              
                | 
					  
                  
				  
                 | 
               
              
              
              
              
              |   |  
              
                
                    
                        | 
                      ¾Ë¸²:  | 
                      µå·°ÀÎÆ÷¿¡¼´Â ÀǾàǰ ÀÎÅÍ³Ý ÆÇ¸Å¸¦ ÇÏÁö ¾Ê½À´Ï´Ù. | 
                     
                    | 
               
            
              
                
                   
                   
                   
                   
		   
                 | 
               
              
                
                  
                     |  
                    
                       Àü¹®/ÀÏ¹Ý | 
		              
                    ÀϹÝ
                       | 
                      
                        
                        
                        
                       | 
                     
                    
                      
					   Á¦Á¶È¸»ç | 
                      
                       
                        űØÁ¦¾à(ÁÖ)
                      
                       | 
                     
                    
                      
					   ÆÇ¸Åȸ»ç | 
                      
                       
			            űØÁ¦¾à(ÁÖ)
                      
                       | 
                     
                      
                      
                      
					   Çã°¡Á¤º¸ | 
                      
                      
                                          Á¤»ó                  
                                          
                          
                                (2003.04.22)
                           
                            
                       | 
                     
                    
                     
                        
	    				   BIT ¾àÈ¿ºÐ·ù | 
                        
                          ¿Ü¿ë ½ºÅ×·ÎÀ̵å (Steroids : Skin & Mucous Membrane)
                         | 
                     
                    
                    
                      
					   º¹ÁöºÎºÐ·ù | 
                      264[ÁøÅ롤Áø¾ç¡¤¼ö·Å¡¤¼Ò¿°Á¦                                        ] | 
                     
                    
                      
					   û±¸ÄÚµå(KDÄÚµå)    ºñ±Þ¿©Á¡°ËÄÚµå | 
                      
                      
                      
                        
644803091   \1,000 ¿ø/20g/°³(2025.04.01)(ÇöÀç¾à°¡)\1,058 ¿ø/20g/°³(2024.04.01) (º¯°æÀü¾à°¡)
                         | 
                        
						     
						     
                         | 
                      
                      
                       | 
                     
                     
                    
                       ATCÄÚµå | 
                      hydrocortisone  / D07AA02 | 
                     
                    
                    
                       NDCÄÚµå | 
                      
                        [Proprietary Name Search _ ƯÇãµî·Ï¸í,»óÇ¥¸íÀ¸·Î °Ë»ö] 
                        [Active Ingredient Search _ ÁÖ¼ººÐÀ¸·Î °Ë»ö] 
                        [NDC Number Search _ NDCÄÚµå·Î °Ë»ö] 
                       | 
                                         
                    
                      
					   ¼ººÐ / ÇÔ·®  | 
                      
			
			
			[½ÉÆò¿ø ÁÖ¼ººÐÄÚµå ±âÁØ ¼ººÐÇÔ·®Á¤º¸ Á¶È¸] 
			
			  
					                            
                       | 
                     
                        
                      
                      
					   ÷°¡Á¦ | 
                      
                      
                           ³ó±Û¸®¼¼¸°,
                          
                           ¶ó¿ì¸±È²»ê³ªÆ®·ý,
                          
                           ·¹Æ¼³îÆÈ¹ÌÅ×ÀÌÆ®À¯,
                          
                           ¹é»ö¹Ù¼¿¸°,
                          
                           º¥Á¶»ê³ªÆ®·ý,
                          
                           ºÎÆ¿·¹ÀÌÆ¼µåÈ÷µå·Ï½ÃÅç·ç¿£,
                          
                           ºÎÆ¿È÷µå·Ï½Ã¾Æ´Ï¼Ö,
                          
                           ¼¼Åº¿Ã,
                          
                           ¼Ò¸£ºñź½ºÅ׾Ʒ¹ÀÌÆ®,
                          
                           ¼ö»êȳªÆ®·ý,
                          
                           ½ºÅ׾Ƹ£»ê,
                          
                           ½ºÅ׾Ƹ±¾ËÄÚ¿Ã,
                          
                           ¾Æ½ºÄÚ¸£ºê»ê,
                          
                           ¾Ë·Î¿¡º£¶ó°Ö,
                          
                           ¿¡µ¥Æ®»ê³ªÆ®·ý¼öȹ°,
                          
                           À¯µ¿ÆÄ¶óÇÉ,
                          
                           ÀÜź°Ë,
                          
                           Á¤Á¦¶ó³î¸°,
                          
                           Á¤Á¦¼ö,
                          
                           ÅäÄÚÆä·Ñ¾Æ¼¼Å×ÀÌÆ®,
                          
                           Æ®·Ñ¾Æ¹Î,
                          
                           ÆÄ¶ó¿Á½Ãº¥Á¶»ê¸ÞÆ¿,
                          
                           ÆÄ¶ó¿Á½Ãº¥Á¶»êÇÁ·ÎÇÊ,
                          
                           Æú¸®¿Á½Ã¿¡Æ¿·»¼¼Æ¿¿¡Å׸£,
                          
                          ÇÁ·ÎÇÊ·»±Û¸®ÄÝ
                                          
                       | 
                     
                   
                  
                 | 
               
              | 
            | 
         
       
       | 
   
    |  
  
    | 
      
     | 
     
  |                   
                                        | 
                                             | 
                                         
                            
                                
                            
                            
                              
                                                        
                              
                                                
                            
 |   
    | 
      
     | 
 
 |  
    
   
    | 
       
        À¯·áȸ¿ø °áÀç½Ã¿¡´Â º¸´Ù ´Ù¾çÇÑ ¾à¹°Á¤º¸¸¦
        ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
        À¯·áÁ¤º¸¸ñ·ÏÀº Àü¹®È¸¿øÀ¸·Î
        ·Î±×ÀÎ ÇϽøé È®ÀÎ °¡´ÉÇÕ´Ï´Ù.
       
     | 
   
  
     | 
   
  
  
    
      
  
    
       |  
      
        
          
            
                | Çã°¡Á¤º¸ | 
             
           
         | 
       
       |  
      
  
    | Ç׸ñ | 
    ³»¿ë | 
   
  
  
  
  
   
    û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå  »óÇÑ±Ý¾× | 
    
      
      
        
        644803091  
	    
	    
            [º¸ÇèÄڵ忡 µû¸¥ ¾àǰ±âº»Á¤º¸ Á÷Á¢Á¶È¸] 
          
        
        
        
          
          
            \1,000 ¿ø/20g/°³(2025.04.01)(ÇöÀç¾à°¡)
            \1,058 ¿ø/20g/°³(2024.04.01)(º¯°æÀü¾à°¡)
        
          
            
	 
  	   
  	   
       
      
       
       
     
      
      
     
      
    
    
    
      
     [»óº´ÄÚµåÁ¶È¸]
      
      [Áúº´ÄÚµåÁ¶È¸]
     
     | 
   
   
    | ºü¸¥Á¶È¸ | 
    
      
     |   
   
  
  
  
   
    | Á¦Ç°¼º»ó | 
    ¹é»öÀÇ Å©¸²Á¦  [Á¦ÇüÁ¤º¸ È®ÀÎ] |   
   
  
  
  
  
  
   
    | Æ÷À塤À¯Åë´ÜÀ§ | 
    10mg¡¿1EA | 
   
  
  
  
   
    | Æ÷À塤ÄÚµå´ÜÀ§ | 
    
        
        
            | ¾àǰ±Ô°Ý | 
            ´ÜÀ§ | 
            Æ÷ÀåÇüÅ | 
            ´ëÇ¥ÄÚµå | 
            Ç¥ÁØÄÚµå | 
            ºñ°í | 
	     
        
        
            | 20±×·¥ | 
            1 °³ | 
            Æ©ºê | 
            8806448030904 | 
            8806448030911 | 
             | 
	     
        
         
     | 
   
      
  
  	
   
    | ÁÖ¼ººÐÄÚµå | 
    
      170932CCM  
      
	  [µ¿ÀÏÇÑ ÁÖ¼ººÐÄڵ带 °¡Áø ¿À¸®Áö³¯ ¶Ç´Â Á¦³×¸¯ ÀǾàǰ Á¶È¸]
     | 
   
  
  
  
 
  
  
    
  
  
  
  
  
  
  
  
  
  
 
  
  
  
 
  
  
  
  
  
  
   
    | Çã°¡»çÇ× ¿ø¹®Á¶È¸ | 
    
      
	    [Çã°¡»çÇ× ¿ø¹®Á¶È¸] 
     | 
   
  
  
  
  
     
  
  
  
   
    | È¿´ÉÈ¿°ú | 
    
    [ÀûÀÀÁõ º° °Ë»ö] 
      
    
     
	 
      ½ÀÁø¤ýÇǺο°±º, ÇǺΰ¡·Á¿ò, ¹ú·¹¹°¸°µ¥
      
     | 
   
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
    
  
  
  
  
  
   
    | ¿ë¹ý¿ë·® | 
    
      * Àý´ë ÀÓÀǺ¹¿ëÇÏÁö ¸¶½Ã°í ¹Ýµå½Ã ÀÇ»ç ¶Ç´Â ¾à»ç¿Í »ó´ãÇϽñ⠹ٶø´Ï´Ù. 
    
     
      
      
      [󹿾à¾î] 
      1ÀÏ 1-3ȸ Àû´ç·®À» ȯºÎ¿¡ ¹Ù¸£°í Áõ»ó¿¡ µû¶ó ÀûÀýÈ÷ Áõ°¨ÇÑ´Ù.      
      	
     | 
   
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
   
    | ±Ý±â | 
    1) ¼¼±Õ(°áÇÙ, ¸Åµ¶ µî)¤ýÁø±Õ(ĵð´ÙÁõ, ¹é¼± µî)¤ý¹ÙÀÌ·¯½º(´ë»óÆ÷Áø, ´Ü¼øÆ÷Áø, ¼öµÎ, Á¾µÎÁõ µî)¤ýµ¿¹°(¿È, »ç¸é¹ßÀÌ µî)¼º ÇǺΰ¨¿°Áõ ȯÀÚ(Áõ»óÀÌ ¾Ç鵃 ¼ö ÀÖ´Ù) 
2) ÀÌ ¾à ¶Ç´Â ÀÌ ¾à ¼ººÐ¿¡ °ú¹ÎÁõ ¹× ±× º´·ÂÀÌ Àִ ȯÀÚ 
3) °í¸· õ°øÀÌ ÀÖ´Â ½ÀÁø¼º ¿ÜÀ̵µ¿° ȯÀÚ(õ°øºÎÀ§ÀÇ Ä¡À¯Áö¿¬ÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù) 
4) ±Ë¾ç(º£Ã¼Æ®º´ Á¦¿Ü), Á¦2µµ ½ÉÀ缺 ÀÌ»óÀÇ È»ó¤ýµ¿»ó ȯÀÚ(ÇǺÎÀç»ýÀÌ ¾ïÁ¦µÇ¾î Ä¡À¯°¡ Áö¿¬µÉ ¼ö ÀÖ´Ù) 
5) ÀÔÁÖÀ§ÇǺο°, º¸Åë¿©µå¸§, ÁÖ»ç ȯÀÚ 
6) 2¼¼ ¹Ì¸¸ À¯¾Æ 
 | 
   
  
  
  
  
   
    | ½ÅÁßÅõ¿© | 
    1) ÀӺΠ¶Ç´Â ÀÓ½ÅÇϰí ÀÖÀ» °¡´É¼ºÀÌ ÀÖ´Â ºÎÀÎ ¹× ¼öÀ¯ºÎ 
2) À¯¤ý¼Ò¾Æ 
3) °í·ÉÀÚ 
4) ÀÌ ¾àÀº ÇÁ·ÎÇÊ·»±Û¸®ÄÝÀ» ÇÔÀ¯Çϰí ÀÖÀ¸¹Ç·Î ÀÌ ¼ººÐ¿¡ °ú¹ÎÇϰųª ¾Ë ·¹¸£±â º´·ÂÀÌ Àִ ȯÀÚ¿¡´Â ½ÅÁßÈ÷ Åõ¿©ÇϽʽÿÀ. 
 | 
   
  
    
  
  
  
  
  
   
    | ÀÌ»ó¹ÝÀÀ | 
    
      1) ÇǺΠ
¨ç °¨¿°Áõ : ÇǺÎÀÇ ¼¼±Õ¼º(Àü¿°¼º ³ó°¡Áø, ¸ð³¶¿° µî) ¹× Áø±Õ¼º(ĵð´ÙÁõ, ¹é¼± µî) °¨¿°ÁõÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù[¹ÐºÀºØ´ë¹ý(ODT)ÀÇ °æ¿ì ³ªÅ¸³ª±â ½±´Ù]. ÀÌ¿Í °°Àº Áõ»óÀÌ ³ªÅ¸³¯ °æ¿ì¿¡´Â ÀûÀýÇÑ Ç×±ÕÁ¦³ª Ç×Áø±ÕÁ¦ µîÀ» º´¿ëÇϰí Áõ»óÀÌ ½Å¼ÓÈ÷ °³¼±µÇÁö ¾ÊÀ» °æ¿ì¿¡´Â »ç¿ëÀ» ÁßÁöÇÑ´Ù. 
¨è ÀϹÝÀû ÇǺÎÁõ»ó : ¸ð³¶¿°, ºÎ½º·³, ÇǺÎÀÚ±Ø, ÀÚÅë, ¹ß¿, ÀÛ¿°¨, ¹ßÁø, ¹ßÀû, È«Á¶, °¡·Á¿ò, ÇǺΰÇÁ¶, ³óÆ÷¼ºÇǺο°, ¾Ë·¹¸£±â¼º Á¢ÃËÇǺο°, ¶¡¶ì, ÇÑÁø, »óó¾ÇÈ, ¿åâ, ³óÆ÷Áõ µîÀÌ ³ªÅ¸³¯ ¼ö ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ Áõ»óÀÌ ³ªÅ¸³¯ °æ¿ì¿¡´Â »ç¿ëÀ» ÁßÁöÇÑ´Ù. 
¨é Àå±â ¿¬¿ë : ½ºÅ×·ÎÀ̵强 ¿©µå¸§, ½ºÅ×·ÎÀ̵强 ÇǺÎ(ÇǺÎÀ§Ãà, ¸ð¼¼Ç÷°üÈ®Àå, ÀÚ¹Ý), ½ºÅ×·ÎÀ̵强 ÁÖ»ç, ÀÔÁÖÀ§ÇǺο°(ÀÔÁÖÀ§¤ý¾È¸éÀüü¿¡ È«¹Ý, ±¸Áø, ¸ð¼¼Ç÷°üÈ®Àå, µüÁö, Àμ³), ¾î¸°¼±(åÛ×÷àÈ)¾ç ÇǺκ¯È, ´Ù¸ð, »ö¼ÒÅ»½Ç, ¼±Á¶, ¼öÆ÷¼ºÇǺο°, ¾ÆÅäÇÇÇǺο°, ÇǺÎÃâÇ÷ µîÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù. ÀÌ·¯ÇÑ Áõ»óÀÌ ³ªÅ¸³¯ °æ¿ì¿¡´Â õõÈ÷ »ç¿ë·®À» ÁÙ¿© ÄÚ¸£Æ¼ÄÚÀ̵带 ÇÔÀ¯ÇÏÁö ¾ÊÀº ¾àÀ¸·Î ¹Ù²Ù¾î »ç¿ëÇÑ´Ù. 
2) ³»ºÐºñ°è : ´ë·® ¶Ç´Â Àå±â°£¿¡ °ÉÄ£ ±¤¹üÀ§ÇÑ »ç¿ë, ¹ÐºÀºØ´ë¹ý¿¡ ÀÇÇØ ÄÚ¸£Æ¼ÄÚÀ̵å Àü½Å Åõ¿©¿Í °°Àº ³úÇϼöü¤ýºÎ½ÅÇÇÁú°è ±â´ÉÀÇ ¾ïÁ¦¸¦ °¡Á®¿Ã ¼ö ÀÖÀ¸¹Ç·Î ÁÖÀÇÇÑ´Ù. 
3) ´« : ¾È°ËÇǺο¡ »ç¿ë½Ã ¾È¾Ð »ó½Â, ³ì³»ÀåÀ» ÀÏÀ¸Å³ ¼ö ÀÖÀ¸¹Ç·Î ÁÖÀÇÇÑ´Ù. ´ë·® ¶Ç´Â Àå±â°£¿¡ °ÉÄ£ ±¤¹üÀ§ÇÑ »ç¿ë, ƯÈ÷ ¹ÐºÀºØ´ë¹ýÀ» »ç¿ëÇÒ °æ¿ì Èij¶ÇϹ鳻Àå, ³ì³»Àå µîÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù. ºóµµºÒ¸íÀÇ ½Ã¾ßÈ帲ÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù. 
      
     | 
   
        
  
  
  
    
  
  
       	
  
     
  
  
  
  
  
   
    | Related FDA Approved Drug | 
    
      
      ±âÁØ ¼ººÐ: HYDROCORTISONEACETASOL HC (ACETIC ACID, GLACIAL; HYDROCORTISONE) 
ACETIC ACID W/ HYDROCORTISONE (ACETIC ACID, GLACIAL; HYDROCORTISONE) 
ACHROMYCIN (HYDROCORTISONE; TETRACYCLINE HYDROCHLORIDE) 
ACTICORT (HYDROCORTISONE) 
ACYCLOVIR AND HYDROCORTISONE (ACYCLOVIR; HYDROCORTISONE) 
AEROSEB-HC (HYDROCORTISONE) 
A-HYDROCORT (HYDROCORTISONE SODIUM SUCCINATE) 
ALA-CORT (HYDROCORTISONE) 
ALA-SCALP (HYDROCORTISONE) 
ALPHADERM (HYDROCORTISONE; UREA) 
ANUSOL HC (HYDROCORTISONE) 
BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE (BACITRACIN; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE) 
BALNEOL-HC (HYDROCORTISONE) 
BETA-HC (HYDROCORTISONE) 
CALMURID HC (HYDROCORTISONE; UREA) 
CARMOL HC (HYDROCORTISONE ACETATE; UREA) 
CETACORT (HYDROCORTISONE) 
CHLOROMYCETIN HYDROCORTISONE (CHLORAMPHENICOL; HYDROCORTISONE ACETATE) 
CIPRO HC (CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE) 
COLOCORT (HYDROCORTISONE) 
COLY-MYCIN S (COLISTIN SULFATE; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; THONZONIUM BROMIDE) 
COR-OTICIN (HYDROCORTISONE ACETATE; NEOMYCIN SULFATE) 
CORT-DOME (HYDROCORTISONE) 
CORTEF (HYDROCORTISONE) 
CORTEF ACETATE (HYDROCORTISONE ACETATE) 
CORTENEMA (HYDROCORTISONE) 
CORTIFOAM (HYDROCORTISONE ACETATE) 
CORTISPORIN (BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE) 
CORTRIL (HYDROCORTISONE) 
DERMACORT (HYDROCORTISONE) 
DRICORT (HYDROCORTISONE ACETATE) 
ELDECORT (HYDROCORTISONE) 
EPICORT (HYDROCORTISONE) 
EPIFOAM (HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE) 
FLEXICORT (HYDROCORTISONE) 
GLYCORT (HYDROCORTISONE) 
HC #1 (HYDROCORTISONE) 
HC #4 (HYDROCORTISONE) 
HC (HYDROCORTISONE) (HYDROCORTISONE) 
H-CORT (HYDROCORTISONE) 
HEMSOL-HC (HYDROCORTISONE ACETATE) 
HI-COR (HYDROCORTISONE) 
HYDROCORTISONE (HYDROCORTISONE) 
HYDROCORTISONE ACETATE (HYDROCORTISONE ACETATE) 
HYDROCORTISONE ACETATE 1% AND PRAMOXINE HYDROCHLORIDE 1% (HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE) 
HYDROCORTISONE AND ACETIC ACID (ACETIC ACID, GLACIAL; HYDROCORTISONE) 
HYDROCORTISONE BUTYRATE (HYDROCORTISONE BUTYRATE) 
HYDROCORTISONE IN ABSORBASE (HYDROCORTISONE) 
HYDROCORTISONE SODIUM PHOSPHATE (HYDROCORTISONE SODIUM PHOSPHATE) 
HYDROCORTISONE SODIUM SUCCINATE (HYDROCORTISONE SODIUM SUCCINATE) 
HYDROCORTISONE VALERATE (HYDROCORTISONE VALERATE) 
HYDROCORTONE (HYDROCORTISONE) 
HYDRO-RX (HYDROCORTISONE) 
HYTONE (HYDROCORTISONE) 
LOCOID (HYDROCORTISONE BUTYRATE) 
LOCOID LIPOCREAM (HYDROCORTISONE BUTYRATE) 
MICORT-HC (HYDROCORTISONE ACETATE) 
NEO-CORT-DOME (ACETIC ACID, GLACIAL; HYDROCORTISONE; NEOMYCIN SULFATE) 
NEO-CORTEF (HYDROCORTISONE ACETATE; NEOMYCIN SULFATE) 
NEOMYCIN & POLYMYXIN B SULFATES & BACITRACIN ZINC & HYDROCORTISONE (BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE) 
NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE (HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE) 
NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE (BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE) 
NEOMYCIN SULFATE, POLYMYXIN B SULFATE & HYDROCORTISONE (HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE) 
NEOMYCIN SULFATE-POLYMYXIN B SULFATE-HYDROCORTISONE (HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE) 
NOGENIC HC (HYDROCORTISONE) 
NUTRACORT (HYDROCORTISONE) 
OPHTHOCORT (CHLORAMPHENICOL; HYDROCORTISONE ACETATE; POLYMYXIN B SULFATE) 
ORABASE HCA (HYDROCORTISONE ACETATE) 
ORLEX HC (ACETIC ACID, GLACIAL; HYDROCORTISONE) 
OTICAIR (HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE) 
OTOBIONE (HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE) 
OTOBIOTIC (HYDROCORTISONE; POLYMYXIN B SULFATE) 
OTOCORT (HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE) 
PANDEL (HYDROCORTISONE PROBUTATE) 
PEDIOTIC (HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE) 
PENECORT (HYDROCORTISONE) 
PRAMOSONE (HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE) 
PROCTOCORT (HYDROCORTISONE) 
PROCTOFOAM HC (HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE) 
PYOCIDIN (HYDROCORTISONE; POLYMYXIN B SULFATE) 
SOLU-CORTEF (HYDROCORTISONE SODIUM SUCCINATE) 
STIE-CORT (HYDROCORTISONE) 
SYNACORT (HYDROCORTISONE) 
TERRA-CORTRIL (HYDROCORTISONE ACETATE; OXYTETRACYCLINE HYDROCHLORIDE) 
TEXACORT (HYDROCORTISONE) 
U-CORT (HYDROCORTISONE ACETATE; UREA) 
VOSOL HC (ACETIC ACID, GLACIAL; HYDROCORTISONE) 
WESTCORT (HYDROCORTISONE VALERATE) 
ZINC BACITRACIN,NEOMYCIN SULFATE,POLYMYXIN B SULFATE & HYDROCORTISONE (BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE) 
        
     | 
      
  
  
  |  
     
   
  
    
       |  
      
        
          
            
                | Á¤º¸¿ä¾à |         
             
           
         | 
             	    
       |  
      | 
  
    µå·°ÀÎÆ÷ ÀǾàǰ ¿ä¾à/»ó¼¼Á¤º¸
    
  
  
    
  
   |  
     
   
  
    
       |  
      
        
          
            
                | ÄÚµå ¹× ºÐ·ùÁ¤º¸ |         
             
           
         | 
             	    
       |  
      | 	 |  
     
   
  
    
       |  
      
        
          
            
                | Á¦Ç°Á¤º¸ |            
             
           
         | 
             	  
       |  
       |  
     
   
  
    
       |  
      
        
          
            
                | º¹¾àÁ¤º¸ |            
             
           
         | 
             	  
       |  
      
  
    | Ç׸ñ | 
    ³»¿ë | 
   
   
    | LACTmed ¹Ù·Î°¡±â | 
    
      
        [¹Ù·Î°¡±â]
     | 
     
  
  
   
    | ¾à¸®ÀÛ¿ë | 
    
       
      À¯·áÁ¤º¸ÀÔ´Ï´Ù.
       
     | 
     
  
  
  
   
    | Ãà¾àº¹¾àÁöµµ | 
    
     
    À¯·áÁ¤º¸ÀÔ´Ï´Ù.
    
     | 
   
       
  
  
   
    | º¹¾àÁöµµ | 
    
     
    À¯·áÁ¤º¸ÀÔ´Ï´Ù.
    
     | 
   
                                                          															
  
   
  
  
   
    | ÀӺο¡´ëÇÑÅõ¿© | 
    
      
      
        
	      
	      
	        | *  | 
	        
	          ÀüüÀӽŠ±â°£º°·Î ¿©·¯µî±ÞÀÌ Á¸ÀçÇÒ ¼ö ÀÖÀ¸¸ç °¡Àå À§Çèµµ°¡ ³ôÀº Á¤º¸¸¸ º¸¿©Áý´Ï´Ù. ´Ü, º¹ÇÕÁ¦ÀÇ °æ¿ì ¸ðµç º¹ÇÕÁ¦¼ººÐ¿¡ ´ëÇÑ ÀÓºÎÅõ¿©µî±ÞÀÌ Ç¥½ÃµÈ°ÍÀº Àý´ë ¾Æ´Ï¸ç Ç¥½ÃµÈ°ÍÁß¿¡ °¡Àå À§Çèµµ°¡ ³ôÀº Á¤º¸¸¸ ³ªÅ¸³³´Ï´Ù. 
	         | 
	         
	       
	       | 
	   
	  
	    |   | 
	   
	  
	    
	      FDA : Cµî±Þ 
				        
				         (hydrocortisone topical )
				        
	   | 
	  
	  
	  
	     
	     
	     
	     
	     
	     
	   | 
	 
	
	  
	      
	      
	        | *  | 
	        
	          »ó±â ÀÓºÎÅõ¿©¿¡ ´ëÇÑ Á¤º¸´Â Àü»êó¸® µÇ¸é¼ ÀÔ·Â ¿À·ù °¡´É¼ºÀÌ Á¸ÀçÇÕ´Ï´Ù. ¿À·ù °¡´É¼ºÀ» ÃÖ¼ÒÈÇϱâ À§ÇÏ¿© ¸¹Àº ³ë·ÂÀ» ±â¿ïÀ̰í ÀÖÀ¸³ª, ±× Á¤È®¼º¿¡ ´ëÇÏ¿© È®½ÅÀ» µå¸± ¼ö ¾ø½À´Ï´Ù. ÀÌ¿¡ ´ëÇØ ȸ»ç´Â Ã¥ÀÓÀ» ÁöÁö ¾Ê½À´Ï´Ù.
	         | 
	         
	      
	        | *  | 
	        
	          ¹Ýµå½Ã °ø½Å·Â ÀÖ´Â ¹®ÇåÀ» ´Ù½Ã Çѹø Âü°í ÇϽñ⠹ٶó¸ç ÀÇ»ç ¶Ç´Â ¾à»çÀÇ ÆÇ´Ü¿¡ µû¶ó Åõ¿©¿©ºÎ°¡ °áÁ¤µÇ¾î¾ß ÇÕ´Ï´Ù.
	         | 
	         
	       
	   | 
	 
       
     | 
   
  
  
  	   
  
  	   
  
  	   
  
  
     
      | Pharmacokinetics | 
      
       
      À¯·áÁ¤º¸ÀÔ´Ï´Ù.
      
       |   
     
  
  
  
  
  
  
  	
  
  
  	
  
  
   
    | Á¦Çüº° º¹¾àÁöµµ | 
    [Å©¸²] | 
   
  
  
   
    | º¸°ü»ó ÁÖÀÇ | 
    
      
    	
     | 
   
  
  
   
    | Á¶Á¦½Ã ÁÖÀÇ | 
    
      
    	
     | 
      
 
 |  
     
   
  
    
       |  
      
        
          
            
                | ½É»çÁ¤º¸ |            
             
           
         | 
             	  
       |  
       |  
     
     
  
    
       |  
      
        
          
            
                | ÇмúÁ¤º¸ |          
             
           
         | 
             	  
       |  
      
  
    | Ç׸ñ | 
    ³»¿ë | 
   
  
    | DUR (ÀǾàǰ»ç¿ëÆò°¡) | 
    º´¿ë±Ý±â :
     
	 °í½ÃµÈ º´¿ë±Ý±â ³»¿ëÀº ¾ø½À´Ï´Ù.
	 
	  [»óÈ£ÀÛ¿ë/º´¿ë±Ý±â°Ë»ö]										
	  ¿¬·É´ë±Ý±â :
      °í½ÃµÈ ¿¬·É±Ý±â ³»¿ëÀº ¾ø½À´Ï´Ù.
      
       [¿¬·É´ë±Ý±â»ó¼¼°Ë»ö]
       
       
        
        
     | 
   
  
   
    | Mechanism of Action | 
    
       Hydrocortisone¿¡ ´ëÇÑ Mechanism_Of_Action Á¤º¸ Hydrocortisone binds to the cytosolic glucocorticoid receptor. After binding the receptor the newly formed receptor-ligand complex translocates itself into the cell nucleus, where it binds to many glucocorticoid response elements (GRE) in the promoter region of the target genes. The DNA bound receptor then interacts with basic transcription factors, causing the increase in expression of specific target genes. The anti-inflammatory actions of corticosteroids are thought to involve lipocortins, phospholipase A2 inhibitory proteins which, through inhibition arachidonic acid, control the biosynthesis of prostaglandins and leukotrienes. Specifically glucocorticoids induce lipocortin-1 (annexin-1) synthesis, which then binds to cell membranes preventing the phospholipase A2 from coming into contact with its substrate arachidonic acid. This leads to diminished eicosanoid production. The cyclooxygenase (both COX-1 and COX-2) expression is also suppressed, potentiating the effect. In another words, the two main products in inflammation Prostaglandins and Leukotrienes are inhibited by the action of Glucocorticoids. Glucocorticoids also stimulate the lipocortin-1 escaping to the extracellular space, where it binds to the leukocyte membrane receptors and inhibits various inflammatory events: epithelial adhesion, emigration, chemotaxis, phagocytosis, respiratory burst and the release of various inflammatory mediators (lysosomal enzymes, cytokines, tissue plasminogen activator, chemokines etc.) from neutrophils, macrophages and mastocytes. Additionally the immune system is suppressed by corticosteroids due to a decrease in the function of the lymphatic system, a reduction in immunoglobulin and complement concentrations, the precipitation of lymphocytopenia, and interference with antigen-antibody binding. 
     | 
   
  
   
    | Pharmacology | 
     
       Hydrocortisone¿¡ ´ëÇÑ Pharmacology Á¤º¸ Hydrocortisone is the most important human glucocorticoid. It is essential for life and regulates or supports a variety of important cardiovascular, metabolic, immunologic and homeostatic functions. Topical hydrocortisone is used for its anti-inflammatory or immunosuppressive properties to treat inflammation due to corticosteroid-responsive dermatoses. Glucocorticoids are a class of steroid hormones characterised by an ability to bind with the cortisol receptor and trigger a variety of important cardiovascular, metabolic, immunologic and homeostatic effects. Glucocorticoids are distinguished from mineralocorticoids and sex steroids by having different receptors, target cells, and effects. Technically, the term corticosteroid refers to both glucocorticoids and mineralocorticoids, but is often used as a synonym for glucocorticoid. Glucocorticoids suppress cell-mediated immunity. They act by inhibiting genes that code for the cytokines IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-8 and TNF-alpha, the most important of which is the IL-2. Reduced cytokine production limits T cell proliferation. Glucocorticoids also suppress humoral immunity, causing B cells to express lower amounts of IL-2 and IL-2 receptors. This diminishes both B cell clonal expansion and antibody synthesis. The diminished amounts of IL-2 also leads to fewer T lymphocyte cells being activated. 
     | 
   
  
   
    | Metabolism | 
    
       Hydrocortisone¿¡ ´ëÇÑ Metabolism Á¤º¸ # Phase_1_Metabolizing_Enzyme:Cytochrome P450 3A4 (CYP3A4) 
     | 
   
  
   
    | Absorption | 
    
       Hydrocortisone¿¡ ´ëÇÑ Absorption Á¤º¸ Topical corticosteroids can be absorbed from normal intact skin. Inflammation and/or other disease processes in the skin increase percutaneous absorption. 
     | 
   
  
   
    | Pharmacokinetics | 
    
       HydrocortisoneÀÇ ¾à¹°µ¿·ÂÇÐÀÚ·á 
	- Èí¼ö : Á÷ÀåÀ» Á¦¿ÜÇÑ ¸ðµç Åõ¿©°æ·Î¿¡¼ ºü¸£°Ô Èí¼öµÈ´Ù.
	
 - ´ë»ç : °£¿¡¼ ´ë»çµÈ´Ù.
	
 - »ý¸®Àû ¹Ý°¨±â : 8¡12½Ã°£
	
 - ¼Ò½Ç : ÁÖ·Î 17-hydroxysteroids¿Í  17-ketosteroidsÀÇ ÇüÅ·Π½Å¹è¼³µÈ´Ù.
		
 -  ¿ëÇØ¼ºÀÌ Å« ´Ù¸¥ ¾à¹°°ú ºñ±³ÇßÀ» ¶§ hydrocortisone acetate´Â ÀÛ¿ë¹ßÇö½Ã°£Àº ´À¸®Áö¸¸ ÀÛ¿ëÁö¼Ó½Ã°£ÀÌ ±æ´Ù.
 
		 -  Hydrocortisone sodium succinate´Â ¹°¿¡ ½±°Ô ³ì¾Æ »¡¸® Ȱ¼ºÈµÈ´Ù.
  	 
     | 
   
  
   
    | Toxicity | 
    
       Hydrocortisone¿¡ ´ëÇÑ Toxicity Á¤º¸ Side effects include inhibition of bone formation, suppression of calcium absorption and delayed wound healing 
     | 
   
  
   
    | Drug Interactions | 
    
       Hydrocortisone¿¡ ´ëÇÑ Drug_Interactions Á¤º¸ Ambenonium	The corticosteroid decreases the effect of anticholinesterasesEdrophonium	The corticosteroid decreases the effect of anticholinesterasesNeostigmine	The corticosteroid decreases the effect of anticholinesterasesPyridostigmine	The corticosteroid decreases the effect of anticholinesterasesAspirin	The corticosteroid decreases the effect of salicylatesBismuth Subsalicylate	The corticosteroid decreases the effect of salicylatesSalicylate-magnesium	The corticosteroid decreases the effect of salicylatesSalicylate-sodium	The corticosteroid decreases the effect of salicylatesSalsalate	The corticosteroid decreases the effect of salicylatesTrisalicylate-choline	The corticosteroid decreases the effect of salicylatesWarfarin	The corticosteroid alters the anticoagulant effectAcenocoumarol	The corticosteroid alters the anticoagulant effectDicumarol	The corticosteroid alters the anticoagulant effectAnisindione	The corticosteroid alters the anticoagulant effectCholestyramine	Cholestyramine decreases the effect of hydrocortisoneColestipol	Cholestyramine decreases the effect of hydrocortisoneAmobarbital	The barbiturate decreases the effect of the corticosteroidAprobarbital	The barbiturate decreases the effect of the corticosteroidButabarbital	The barbiturate decreases the effect of the corticosteroidButalbital	The barbiturate decreases the effect of the corticosteroidButethal	The barbiturate decreases the effect of the corticosteroidDihydroquinidine barbiturate	The barbiturate decreases the effect of the corticosteroidHeptabarbital	The barbiturate decreases the effect of the corticosteroidHexobarbital	The barbiturate decreases the effect of the corticosteroidMethohexital	The barbiturate decreases the effect of the corticosteroidMethylphenobarbital	The barbiturate decreases the effect of the corticosteroidPentobarbital	The barbiturate decreases the effect of the corticosteroidPhenobarbital	The barbiturate decreases the effect of the corticosteroidPrimidone	The barbiturate decreases the effect of the corticosteroidQuinidine barbiturate	The barbiturate decreases the effect of the corticosteroidSecobarbital	The barbiturate decreases the effect of the corticosteroidTalbutal	The barbiturate decreases the effect of the corticosteroidRifampin	The enzyme inducer decreases the effect of the corticosteroidPhenytoin	The enzyme inducer decreases the effect of the corticosteroidMephenytoin	The enzyme inducer decreases the effect of the corticosteroidFosphenytoin	The enzyme inducer decreases the effect of the corticosteroidEthotoin	The enzyme inducer decreases the effect of the corticosteroidMidodrine	Increased arterial pressure 
     | 
   
  
   
    CYP450  Drug Interaction | 
    
      [CYP450 TableÁ÷Á¢Á¶È¸] 
     | 
   
  
   
    | Food Interaction | 
    
       Hydrocortisone¿¡ ´ëÇÑ Food Interaction Á¤º¸ Take with food to reduce irritation. Calcium, phosphorous, potassium, Vitamin A, C, D and zinc needs increased with long term use. 
     | 
   
  
   
    | Drug Target | 
    
      
      [Drug Target]
     | 
   
  
   
    | Description | 
    
       Hydrocortisone¿¡ ´ëÇÑ Description Á¤º¸ The main glucocorticoid secreted by the adrenal cortex. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. [PubChem] 
     | 
   
  
   
    | Dosage Form | 
    
       Hydrocortisone¿¡ ´ëÇÑ Dosage_Form Á¤º¸ Aerosol	RectalCream	TopicalEnema	RectalLiquid	TopicalLotion	TopicalOintment	OphthalmicOintment	TopicalPowder, for solution	IntramuscularPowder, for solution	IntravenousTablet	Oral 
     | 
   
  
   
    | Drug Category | 
    
       Hydrocortisone¿¡ ´ëÇÑ Drug_Category Á¤º¸ Anti-inflammatory Agents 
     | 
   
  
   
    | Smiles String Canonical | 
    
       Hydrocortisone¿¡ ´ëÇÑ Smiles_String_canonical Á¤º¸ CC12CCC(=O)C=C1CCC1C3CCC(O)(C(=O)CO)C3(C)CC(O)C21 
     | 
   
  
   
    | Smiles String Isomeric | 
    
       Hydrocortisone¿¡ ´ëÇÑ Smiles_String_isomeric Á¤º¸ C[C@]12CCC(=O)C=C1CC[C@H]1[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@H]21 
     | 
   
  
   
    | InChI Identifier | 
    
       Hydrocortisone¿¡ ´ëÇÑ InChI_Identifier Á¤º¸ InChI=1/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1 
     | 
   
  
   
    | Chemical IUPAC Name | 
    
       Hydrocortisone¿¡ ´ëÇÑ Chemical_IUPAC_Name Á¤º¸ (8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one 
     | 
   
  
   
    | Drug-Induced Toxicity Related Proteins | 
    
      HYDROCORTISONE ÀÇ Drug-Induced Toxicity Related ProteinÁ¤º¸ Replated Protein:Interleukin-8  Drug:hydrocortisone Toxicity:inflammation.  [¹Ù·Î°¡±â] 
     | 
   
    
  |  
     
     
  
    
       |  
      
        
          
            
                | »ç¿ëÀÚÄÁÅÙÃ÷ |           
             
           
         | 
             	  
       |  
       |  
     
         
 
     | 
   
   
     | 
   
  
    
      
        
          
            
              - 
                ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2024-08-09
              
 
              - 
                
                 º» ¼öÁ¤ÀÏ Á¤º¸´Â Çã°¡Á¤º¸ ÀÌ¿ÜÀÇ ±âŸÁ¤º¸ ¼öÁ¤ÀÏÀ» ÀǹÌÇϹǷÎ, Çã°¡Á¤º¸¼öÁ¤ÀÏÀº º»¹®¿¡ Ç¥±âµÈ ³¯Â¥¸¦ ÂüÁ¶ÇϽñ⠹ٶø´Ï´Ù.
                
              
     
             
         |                 
       
     |       
          
                
                    
                       ¾Ë¸² | 
                       
                      »ó¼¼Á¤º¸´Â ½ÄǰÀǾàǰ¾ÈÀüóÀÇ Á¦Ç°Çã°¡»çÇ×À» Åä´ë·Î ÀÛ¼ºµÇ¾úÀ¸¸ç ¿ä¾àÁ¤º¸´Â »ó¼¼Á¤º¸ ¹× ±âŸ¹®ÇåÀ» ±â¹ÝÀ¸·Î µå·°ÀÎÆ÷¿¡¼ ÆíÁýÇÑ ³»¿ëÀÔ´Ï´Ù. Á¦Ç°Çã°¡»çÇ×ÀÇ ¸ñÂ÷¿Í ´Ù¼Ò »óÀÌÇÒ ¼ö ÀÖ½À´Ï´Ù.  | 
                    
                    | 
               
      
      
                
                    
                       °æ°í | 
                     
                      µå·°ÀÎÆ÷ ÀǾàÇмúÁ¤º¸´Â ½ÄǰÀǾàǰ¾ÈÀüóÀÇ Á¦Ç°Çã°¡»çÇ×, Çмú¹®Çå, Á¦¾àȸ»ç Á¦°øÁ¤º¸ µîÀ» ±Ù°Å·Î ÀÛ¼ºµÈ Âü°í Á¤º¸ÀÔ´Ï´Ù. 
                          Á¤º¸ÀÇ Á¤È®¼ºÀ» À§ÇØ ³ë·ÂÇϰí ÀÖÀ¸³ª ÆíÁý»óÀÇ ¿À·ù, Çã°¡»çÇ× º¯°æ, Ãß°¡ÀûÀÎ Çмú¿¬±¸ ¶Ç´Â Àӻ󿬱¸ ¹ßÇ¥ µîÀ¸·Î ÀÎÇØ ¹ß»ýÇÏ´Â ¹®Á¦¿¡ ´ëÇØ µå·°ÀÎÆ÷´Â 
                          Ã¥ÀÓÀ» ÁöÁö ¾Ê½À´Ï´Ù. ÀÚ¼¼ÇÑ ³»¿ëÀº ¡°Ã¥ÀÓÀÇ ÇÑ°è ¹× ¹ýÀû°íÁö¡±¸¦ ÂüÁ¶ÇØ ÁֽʽÿÀ.
                            ¹Ýµå½Ã Á¦Á¶¡¤¼öÀÔ»ç, ÆÇ¸Å»ç, ÀÇ»ç, ¾à»ç¿¡°Ô ÃÖÁ¾ÀûÀ¸·Î È®ÀÎÇϽñ⠹ٶø´Ï´Ù.
                          ÀüÈ: 02-3486-1061 ¤Ó À̸ÞÀÏ: webmaster@druginfo.co.kr
 | 
  
                    | 
               
  
 
  
    ¾Æ·¡ÀÇ ³»¿ëÀ» Æ÷ÇÔÇÑ Àüü µ¥ÀÌÅ͸¦ º¸½Ã·Á¸é 
    ¿©±â·Î À̵¿ÇϽñ⠹ٶø´Ï´Ù.
   
  
 
  º´¿ë±Ý±â ¹× ƯÁ¤¿¬·É´ë ±Ý±â ¼ººÐ
 
  
  |  
                           
                         | 
                       
                      | 
                   |